
Capsules 250 mg
Composition: One capsule contains: Active ingredient: lyophilised Saccharomyces boulardii yeast 250.0 mg. Excipients: lactose monohydrate, magnesium stearate. Capsule shell: gelatin, titanium dioxide.
Form: Capsules
Indications: Acute and chronic diarrhea of bacterial etiology in adults and children; acute diarrhea of viral etiology; intestinal dysbacteriosis; prevention and treatment of traveler's diarrhea; AIDS-associated diarrhea; prevention and treatment of colitis and diarrhea caused by antibiotics; irritable bowel syndrome; pseudomembranous colitis and diseases caused by Clostridium difficile; diarrhea caused by prolonged enteral nutrition.
Contraindications: Hypersensitivity (allergy) to any component of the drug; patients with a central venous catheter; galactosemia, lactase deficiency, glucose-galactose malabsorption syndrome; children under 6 years of age (due to the dosage form).
Dosage: Swallow the capsule whole with a small amount of warm liquid. Children aged 6–12: 1 capsule 1–2 times daily. Adults and children over 12: 1–2 capsules twice daily. Recommended treatment course: • Acute diarrhoea: 3–5 days. • Acute and chronic bacterial diarrhoea and irritable bowel syndrome: 10–14 days. • Prevention and treatment of antibiotic-associated diarrhoea and pseudomembranous colitis: 2 capsules twice daily together with antibiotics throughout the antibiotic course.
Warnings: Do not take simultaneously with antifungal medicines when administered orally or parenterally. Enterol 250 should not be mixed with very hot (above 50°C) or very cold food or liquid. Do not take with alcohol.
Age restrictions: Powder: in newborns, no more than 1 sachet per day under a doctor's supervision; capsules: contraindicated in children under 6 years of age.
Pregnancy: Enterol 250 should be used during pregnancy and breastfeeding only in cases where the expected benefit to the mother outweighs the potential risk to the fetus or child.
Country of origin: France
Manufacturer: Biocodex
Storage conditions: Store protected from light at a temperature not exceeding 25°C. Keep out of reach of children.
Literature Review, 2019
Authors: Nuraliyeva Rano Matyakubovna – head of clinical pharmacology course
ReadScientific Review, 2019
Authors: V.O. Kaibysheva, E.L. Nikonov
ReadActa medica Eurasica, 2017
Authors: V.V. Zakharova, L.M. Karzakova
ReadDiseases of the Esophagus and Stomach, 2017
Authors: S.I. Pimanov, E.V. Makarenko
ReadDiseases of the upper digestive tract, 2015
Authors: A.N. Kazyulin
ReadExperimental and Clinical Gastroenterology, 2018
Authors: P.V. Seliverstov, S.I. Sitkin, V.G. Radchenko, L.B. Lazebnik, E.B. Avalueva, T.Ya. Vakhitov, E.V. Demyanova, T.E. Skvortsova, E.M. Prikhodko, M.A. Suvorova
ReadBowel Diseases, 2020
Authors: V.N. Drozdov, K.I. Arefyev, S.Yu. Serebrova, E.V. Shikh
ReadConsilium Medicum. Pediatrics, 2014
Authors: E.A. Kornienko
ReadConsilium Medicum. Pediatrics, 2015
Authors: N.I. Ursova
ReadWorld Journal of Gastroenterology, 2010
Authors: Lynne V McFarland
Read